Top Markets
Coin of the day
Sinew Pharma Inc. Sinew Pharma Inc.

Sinew Pharma Inc.

6634
Pozycja w akcjach #20222
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
Cena akcji
$1.91
Kapitalizacja rynkowa
$136.47M
Zmiana (1 dzień)
-1.15%
Zmiana (1 rok)
21.17%
Kraj
TW
Handel Sinew Pharma Inc. (6634)

Kategoria

Historia ceny akcji dla Sinew Pharma Inc. (6634)
Najwyższa cena zamknięcia: $1.89 dnia 2026-08-01

Najniższa cena zamknięcia: $1.60 dnia 2017-06-01
Historia cen akcji firmy Sinew Pharma Inc. od 2017 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 19.74%
2025 -14.90%
2024 -33.41%
2023 -38.58%
2022 20.56%
2021 26.00%
2020 195.09%
2019 88.41%
2018 -46.85%
2017 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$547.80 38.64%
US
$1.01K 53.55%
NL
$119.27 -15.19%
AU
$766.03 8.39%
CH
$132.57 388.82%
US